BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Smyth EC, Cunningham D. Operable gastro-oesophageal junctional adenocarcinoma: Where to next? World J Gastrointest Oncol 2014; 6(6): 145-155 [PMID: 24936225 DOI: 10.4251/wjgo.v6.i6.145]
URL: https://www.wjgnet.com/1948-5204/full/v6/i6/145.htm
Number Citing Articles
1
L. Alexandre, A. B. Clark, S. Walton, M. P. Lewis, B. Kumar, E. C. Cheong, H. Warren, S. S. Kadirkamanathan, S. L. Parsons, S. M. Dresner, E. Sims, M. Jones, M. Hammond, M. Flather, Y. K. Loke, A. M. Swart, A. R. Hart. Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility studyBJS Open 2020; 4(1): 59 doi: 10.1002/bjs5.50239
2
Arnaud Pasquer, Caroline Gronnier, Florence Renaud, Alain Duhamel, Jérémie Théreaux, Nicolas Carrere, Johan Gagniere, Bernard Meunier, Denis Collet, Christophe Mariette. Impact of Adjuvant Chemotherapy on Patients with Lymph Node-Positive Esophageal Cancer who are primarily Treated with SurgeryAnnals of Surgical Oncology 2015; 22(S3): 1340 doi: 10.1245/s10434-015-4658-1